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Patient care is the primary focus of the orthopaedic pro-
fession. The enhancement of patient care has required and
will continue to require orthopaedic surgeons to collaborate
productively with industry to develop new medical tech-
nology and techniques that improve patient care. The
relationship between orthopaedic surgeons and industry is
of critical importance to the shared ultimate goal of
improving patient care. Orthopaedic surgeons are well
qualiﬁed to provide innovative ideas and feedback to
industry, conduct research trials, serve on scientiﬁc advi-
sory boards, and serve as faculty to teach the uses of new
technology. The relationship between orthopaedic surgeons
and industry is important and necessary, but it must be
scrutinized carefully to avoid the pitfalls of real or per-
ceived conﬂicts of interest that ultimately could affect
patient care.
In late September, four orthopaedic manufacturing
companies entered into Deferred Prosecution Agreements,
agreeing to pay civil settlements amounting to a total of
$311 million. In addition, one orthopaedic company
entered into a Non-Prosecution Agreement. All will be
subject to oversight by a federal monitor appointed by the
U.S. Department of Justice for 18 months. The companies
did not admit any wrongdoing, plead guilty to any criminal
charges or pay any criminal ﬁnes as part of the settlement.
The federal government, through the U.S. Attorney’s
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Editor’s note: The editors of numerous journals in orthopaedics are
running this or a similar editorial. As a group we feel the issue of
transparency with patients about orthopaedic surgeons’ relationships
with industry is complex and important, and every orthopaedic
surgeon should be familiar with the new AAOS SOPs on
Orthopaedist-Industry Conﬂicts of Interest. They may be found at
www.aaos.org/industryrelationships. The article is reproduced with
permission of the AAOS.
R. A. Brand (&)
Clinical Orthopaedics and Related Research
J. A. Buckwalter, T. M. Wright
Journal of Orthopaedic Research
S. Terry Canale
AAOS Now
W. P. Cooney III








Journal of Bone and Joint Surgery, American Volume
R. N. Hensinger, G. H. Thompson
Journal of Pediatric Orthopaedics
L. Andrew Koman
Journal of Surgical Orthopaedic Advances
P. D. McCann
American Journal of Orthopedics
G. G. Poehling, J. H. Lubowitz
Arthroscopy
D. Thordarson
Foot and Ankle International
R. J. Neviaser
Journal of Shoulder and Elbow Surgery
123
Clin Orthop Relat Res (2008) 466:517–519
DOI 10.1007/s11999-007-0078-2Ofﬁce in New Jersey, has agreed not to pursue any criminal
charges against the companies if they comply with the
Agreements. Clearly, a spotlight has been shone on com-
panies and orthopaedic surgeons alike.
Earlier in the year, the Fellowship of the American
Association of Orthopaedic Surgeons (AAOS) adopted
Standards of Professionalism on Orthopaedist-Industry
ConﬂictsofInterest(SOPs).OfthoseFellowsvoting(5242),
approximately 96% voted to adopt these SOPs. These SOPs
establish mandatory, minimum levels of acceptable conduct
for Fellows and Members of AAOS who engage in rela-
tionships with industry. They focus on how orthopaedic
surgeons serve the best interests of the patient and the pro-
fession while participating in academic or commercial
ventures.Thereare 17standards*relating toindustry;itisin
every surgeon’s best interest to be familiar with all 17. The
SOPs address such topics as consulting agreements, indus-
try-sponsored events, inappropriate ﬁnancial arrangements,
CME courses, and gifts from industry. Each of these stan-
dards addresses a real or perceived conﬂict that has the
potential to inﬂuence decisions about patient care and to do
so in a way that is not in the best interests of the patient or
ultimately may increase risks for or even cause injury to the
patient.
The AAOS SOPs emphasize the patient-physician rela-
tionship. The mandatory standards call for orthopaedic
surgeons to tell patients about their relationships with
industrythat create real orperceived conﬂicts of interest and
to resolve these conﬂicts in the best interest of the patient.
Some orthopaedic surgeons may ﬁnd that the SOPs validate
their existing practices. Other orthopaedic surgeons may
wish to revise how their practices address possible conﬂicts.
AAOS will begin enforcing these SOPs for acts occur-
ring on or after January 1, 2008. As with the other AAOS
SOPs, allegations that a Fellow has violated any of the
SOPs on Orthopaedist-Industry Conﬂicts of Interest may
result in a formal grievance under the AAOS Professional
Compliance Program. Orthopaedic surgeons found in vio-
lation of the SOPs may be censured, suspended, or expelled
from the AAOS.
We encourage each of you to become familiar with the
SOPs on Orthopaedist-Industry Conﬂicts of Interest and to
discuss them with your colleagues. Avoiding the pitfalls of
real or perceived conﬂicts of interest with industry
enhances your personal professionalism. Maintaining pro-
ductive relationships with industry that advance patient
care enhances the entire orthopaedic profession.
*Mandatory standards [excerpted from the complete
Standards of Professionalism (SOPs) on Orthopaedist-
Industry Conﬂicts of Interest]:
1. An orthopaedic surgeon shall, while caring for and
treating a patient, regard his or her responsibility to
the patient as paramount.
2. An orthopaedic surgeon shall prescribe drugs,
devices, and other treatments primarily on the basis
of medical considerations and patient needs, regard-
less of any direct or indirect interests in or beneﬁt
from industry.
3. An orthopaedic surgeon convicted of violating fed-
eral or state conﬂict of interest laws or regulations
shall be subject to discipline under the AAOS
Professional Compliance Program.
4. An orthopaedic surgeon shall, when treating a
patient, resolve conﬂicts of interest in accordance
with the best interest of the patient, respecting a
patient’s autonomy to make health care decisions.
5. An orthopaedic surgeon shall notify the patient of his
or her intention to withdraw from the patient-
physician relationship, in a manner consistent with
state law, if a conﬂict of interest cannot be resolved
in the best interest of the patient.
6. An orthopaedic surgeon shall decline subsidies or
other ﬁnancial support from industry, except that an
orthopaedic surgeon may accept gifts having a fair
market value of less than $100, medical textbooks, or
patient educational materials.
7. An orthopaedic surgeon who has inﬂuence in select-
ing a particular product or service for an entity shall
disclose any relationship with industry to colleagues,
the institution and other affected entities.
8. An orthopaedic surgeon shall disclose to the patient
any ﬁnancial arrangements with industry that relate
to the patient’s treatment, including the receipt of
inventor royalties, stock options or paid consulting
arrangements with industry.
9. An orthopaedic surgeon shall accept no direct
ﬁnancial inducements from industry for utilizing a
particular implant or for switching from one manu-
facturer’s product to another.
10. An orthopaedic surgeon shall enter into consulting
agreements with industry only when such arrange-
ments are established in advance and in writing to
include evidence of the following:
• Documentation of an actual need for the service;
• Proof that the service was provided;
• Evidence that physician reimbursement for con-
sulting services is consistent with fair market
value; and
• Not based on the volume or value of business he
or she generates.
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at only those meetings that are conducted in clinical,
educational, or conference settings conducive to the
effective exchange of information.
12. An orthopaedic surgeon shall accept no ﬁnancial
support from industry to attend industry-related social
functions where there is no educational element.
13. An orthopaedic surgeon who is attending a CME
event shall accept no industry ﬁnancial support for
attendance at a CME event. Residents and orthopae-
dists-in-training may accept an industry grant to
attend a CME event if they are selected by their
training institution or CME sponsor and the payment
is made by the training program or CME sponsor.
Bona ﬁde faculty members at a CME event may
accept industry-supported reasonable honoraria, tra-
vel expenses, lodging and meals from the conference
sponsors.
14. An orthopaedic surgeon, when attending an industry-
sponsored non-CME educational event, shall accept
only tuition, travel and modest hospitality, including
meals and receptions; the time and focus of the event
must be for education or training.
15. An orthopaedic surgeon, when attending an industry-
sponsored non-CME educational event, shall accept
no ﬁnancial support for meals, hospitality, travel, or
other expenses for his or her guests or for any other
person who does not have a bona ﬁde professional
interest in the information being shared at the
meeting.
16. An orthopaedic surgeon, when reporting on clinical
research or experience with a given procedure or
device, shall disclose any ﬁnancial interest in that
procedure or device if he or she or any institution
with which he or she is connected has received
anything of value from its inventor or manufacturer.
17. An orthopaedic surgeon who is the principal inves-
tigator shall make his or her best efforts to ensure at
the completion of the study that relevant research
results are reported and reported truthfully and
honestly with no bias or inﬂuence from funding
sources, regardless of positive or negative ﬁndings.
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